Ralph J. Tuthill

Cleveland Clinic — United States

Medicine · Health Sciences

34h-index3.9kcitations103works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cutaneous Melanoma Detection and Management(20), Melanoma and MAPK Pathways(10), Cancer and Skin Lesions(10), Immunotherapy and Immune Responses(9), Eosinophilic Disorders and Syndromes(9)

Publications103 total

Perianal Extramammary Paget’s Disease
2025
Southwest Oncology Group S0008: A Phase III Trial of High-Dose Interferon Alfa-2b Versus Cisplatin, Vinblastine, and Dacarbazine, Plus Interleukin-2 and Interferon in Patients With High-Risk Melanoma—An Intergroup Study of Cancer and Leukemia Group B, Children's Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group
Journal of Clinical Oncology·2014· 107 cited
Adjuvant Vaccine Immunotherapy of Resected, Clinically Node-Negative Melanoma: Long-term Outcome and Impact of HLA Class I Antigen Expression on Overall Survival
Cancer Immunology Research·2014· 13 citedOpen Access
Acantholytic dyskeratosis occurring within an epidermal nevus.
PubMed·2013· 1 cited
A Unique Cause of Intestinal and Splenic Infarction in a Sickle Cell Trait Patient
Case Reports in Surgery·2013· 7 citedOpen Access
Thrombospondin-1 expression in melanoma is blocked by methylation and targeted reversal by 5-Aza-deoxycytidine suppresses angiogenesis
Matrix Biology·2012· 48 citedOpen Access
Phase III trial of high-dose interferon alpha-2b versus cisplatin, vinblastine, DTIC plus IL-2 and interferon in patients with high-risk melanoma (SWOG S0008): An intergroup study of CALGB, COG, ECOG, and SWOG.
Journal of Clinical Oncology·2012· 22 cited
Abstract 868: Oral SHP-1 inhibitor TPI-1a4 increases TILs in melanoma tumors and interacts positively with CTLA4 antibody for melanoma cure in mice
Cancer Research·2012
A 48-year-old woman with an ecchymotic rash
Cleveland Clinic Journal of Medicine·2012Open Access
Iconography : A case of recurrent pseudolymphomatous folliculitis: A mimic of cutaneous lymphoma
2011
Re-Inventing Intratumoral Immunotherapy for Melanoma
Immunotherapy·2011· 21 cited
A phase 2 trial of complete resection for stage IV melanoma
Cancer·2011· 163 citedOpen Access
Weedon's Skin Pathology
The American Journal of Surgical Pathology·2010· 220 cited
Adenoid cystic carcinoma of the base of the tongue
International Journal of Surgery Case Reports·2010· 18 citedOpen Access
Tyrosine Phosphatase Inhibitor-3 Sensitizes Melanoma and Colon Cancer to Biotherapeutics and Chemotherapeutics
Molecular Cancer Therapeutics·2010· 18 citedOpen Access
Should unknown primary melanomas be excluded from adjuvant therapy trials? Insights from SWOG S0008.
Journal of Clinical Oncology·2010· 5 cited
A Phase II Trial of Imatinib Mesylate in Merkel Cell Carcinoma (Neuroendocrine Carcinoma of the Skin)
American Journal of Clinical Oncology·2010· 86 citedOpen Access
JAAD Grand Rounds quiz∗
Journal of the American Academy of Dermatology·2009· 2 cited
A case of recurrent pseudolymphomatous folliculitis: A mimic of cutaneous lymphoma
Journal of the American Academy of Dermatology·2009· 18 cited
A phase II trial of imatinib mesylate in Merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group Study (S0331)
Journal of Clinical Oncology·2009· 9 cited
page 1 of 6Next →

Frequent Co-authors

Wilma F. Bergfeld(10), Vernon K. Sondak(7), Lawrence E. Flaherty(7), Jeffrey A. Sosman(5), Mahmoud R. Hussein(5), Oscar Sudilovsky(5), Bruce G. Redman(4), Eduardo Roggero(4), Eulalia C. Sudilovsky(4), Gary S. Wood(4), Joseph M. Unger(3), John A. Thompson(3), James Moon(3), John T. Vetto(3), Joan Guitart(3), James T. McMahon(3), Min Sun(3), Ernest C. Borden(3), P. Y. Liu(2), R. Dirk Noyes(2)